Osthole Stimulates Osteoblast Differentiation and Bone Formation by Activation of β-Catenin–BMP Signaling

Osteoporosis is defined as reduced bone mineral density with a high risk of fragile fracture. Current available treatment regimens include antiresorptive drugs such as estrogen receptor analogues and bisphosphates and anabolic agents such as parathyroid hormone (PTH). However, neither option is comp...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tang, De-Zhi, Hou, Wei, Zhou, Quan, Zhang, Minjie, Holz, Jonathan, Sheu, Tzong-Jen, Li, Tian-Fang, Cheng, Shao-Dan, Shi, Qi, Harris, Stephen E, Chen, Di, Wang, Yong-Jun
Format: Artigo
Langue:Inglês
Publié: Wiley Subscription Services, Inc., A Wiley Company 2010
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3153131/
https://ncbi.nlm.nih.gov/pubmed/20200936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.21
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires